Literature DB >> 28276054

Hospital-based epidemiological and clinical characterisation of the malignant transformation of oral leukoplakia in a Chinese population.

Ming-Yue Lyu1, Yu-Si Guo2, Shuo Li2, Di Yang2, Hong Hua3.   

Abstract

OBJECTIVE: The aim of this review was to analyse, systematically, hospital-based epidemiological information concerning the malignant transformation rate (MTR) of oral leukoplakia (OL) in a Chinese population, as well as the associated risk factors.
METHODS: Four electronic databases were searched for studies dealing with OL and related risk factors, including age, gender, type of lesion, site, and smoking and drinking habits.
RESULTS: The MTR of OL in the hospital-based Chinese population ranged from 4% to 13%, based on the studies analysed. Regarding risk factors, we found that female patients had a higher MTR than male patients, and that patients older than 50 years of age also had a higher MTR. Patients who smoked had a lower MTR, while alcohol consumption seemed to have no association with MTR. Malignant transformation occurred most commonly on the tongue. Regarding lesion type, non-homogeneous OL had a higher MTR, with the granular type having the highest MTR. Our results regarding the epidemiology of OL showed a similar trend to those reported in western populations and provided preliminary epidemiological information on the Chinese population.
CONCLUSIONS: Our findings show that female gender, age >50 years and non-homogeneous OL are risk factors for malignant transformation. It is important to develop clinical strategies to educate, diagnose and treat patients with OL and to minimise the MTR of OL.
© 2017 FDI World Dental Federation.

Entities:  

Keywords:  Chinese population; Oral leukoplakia; malignant transformation; risk factor

Mesh:

Year:  2017        PMID: 28276054      PMCID: PMC9378875          DOI: 10.1111/idj.12292

Source DB:  PubMed          Journal:  Int Dent J        ISSN: 0020-6539            Impact factor:   2.607


  35 in total

1.  Studies in oral leukoplakia: a preliminary report on the period pervalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients.

Authors:  J J Pindborg; O Jolst; G Renstrup; B Roed-Petersen
Journal:  J Am Dent Assoc       Date:  1968-04       Impact factor: 3.634

2.  [A retrospective analysis on the malignant transformation rate, time and risk factors of oral leukoplakia].

Authors:  Yu-feng Wang; Shu Shang; Zeng-tong Zhou; Guo-yao Tang
Journal:  Shanghai Kou Qiang Yi Xue       Date:  2011-02

Review 3.  Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions.

Authors:  T Axéll; J J Pindborg; C J Smith; I van der Waal
Journal:  J Oral Pathol Med       Date:  1996-02       Impact factor: 4.253

4.  Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias.

Authors:  C A Waldron; W G Shafer
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

5.  [Analysis of risk factors for carcinogenesis of oral leukoplakia].

Authors:  Ai-xian Lan; Xiao-bing Guan; Zheng Sun
Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi       Date:  2009-06

6.  Oral leukoplakia. A histopathological study.

Authors:  I Rodriguez-Pérez; J Bánóczy
Journal:  Acta Morphol Acad Sci Hung       Date:  1982

7.  Presence of human papillomavirus DNA in benign and precancerous oral leukoplakias and squamous cell carcinomas.

Authors:  A Gassenmaier; O P Hornstein
Journal:  Dermatologica       Date:  1988

8.  Follow-up studies in oral leukoplakia.

Authors:  J Bánóczy
Journal:  J Maxillofac Surg       Date:  1977-02

9.  Oral cancer development in patients with leukoplakia--clinicopathological factors affecting outcome.

Authors:  Wei Liu; Lin-Jun Shi; Lan Wu; Jin-Qiu Feng; Xi Yang; Jiang Li; Zeng-Tong Zhou; Chen-Ping Zhang
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

10.  The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients.

Authors:  Elisabeth-R E A Brouns; Jacques-A Baart; Elisabeth Bloemena; Hakki Karagozoglu; Isaäc van der Waal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-01-01
View more
  4 in total

1.  Transcriptome array screening and verification of oral leukoplakia carcinogenesis-related hypoxia-responsive gene and microRNA.

Authors:  Lin-Jun Shi; Xi Yang; Su-Ning Wu; Wei Liu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

2.  Human papillomavirus genotypes and p16 expression in oral leukoplakia and squamous cell carcinoma.

Authors:  Li-Qun Yang; Xuan Xiao; Chen-Xi Li; Wen-Yan Wu; Xue-Min Shen; Zeng-Tong Zhou; Yuan Fan; Lin-Jun Shi
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

3.  Application of 5-aminolevulinic acid-mediated Waterlase-assisted photodynamic therapy in the treatment of oral leukoplakia.

Authors:  Jiali Ou; Yijun Gao; Huan Li; Tianyou Ling; Xiaoyan Xie
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

4.  Photodynamic therapy guidelines for the management of oral leucoplakia.

Authors:  Qianming Chen; Hongxia Dan; Fan Tang; Jiongke Wang; Xiaoying Li; Junxin Cheng; Hang Zhao; Xin Zeng
Journal:  Int J Oral Sci       Date:  2019-04-11       Impact factor: 6.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.